We have long recognised the link between planetary and human health. Ensuring good health and improving lives drives what we do, striving to do now what patients need next.
With climate change causing an alarming number of negative health impacts – from respiratory disease due to air pollution to the spread of malaria resulting from deforestation – Roche sees tackling climate change as integral to its purpose as a global business.
We are taking concrete action to fight climate change and protect our planet now and in the future. We will continue to review our targets and strategy, and invest in innovation, to reach zero emissions as quickly as possible.
Roche is committed to reducing our carbon emissions across Scopes 1 and 2 to absolute zero by 2050 and to ensure we more than support the Paris Goal of 1.5 degrees, which we are on track to do.
In the UK, Roche has reduced CO2 emissions per employee by a quarter, and we have reduced energy use by twice that of the average firm in the UK.
Reduction in CO2 emissions per employee across the two Roche locations in the UK from 2014-2019
Reduction in energy consumption per employee across the two Roche locations in the UK from 2014-2019
We also have an Eco Crew, a group of Roche UK employees who aim to educate and inspire colleagues, and contribute to site and global sustainability initiatives, as well as running local ones.
Since the Eco Crew was founded in 2019, they have been instrumental in initiatives like reducing the amount of single use plastic on site, the role out of ESG pensions and challenging colleagues to bring more sustainable options into their day-to-day life (e.g. Plastic Free July and Greener Christmas challenges, which 80+ colleagues took part in).
Healthcare matters to all of us and doesn’t discriminate. That’s why we work hard to ensure that all our new medicines and tests are made available to those who need them through the NHS - wherever they live, whatever their circumstances.
Universal access to quality healthcare and medical innovation remains a global challenge. To address this challenge, many of the world’s top relief and aid organisations have joined together with an ambitious goal: to eliminate many diseases.
In support of this ambition, Roche Diagnostics launched a Global Access Program which provides access to diagnostics for HIV, hepatitis, tuberculosis and cervical cancer (HPV), in high disease burden and qualified countries where reliable diagnostic solutions are needed most.
